AMIR LAVAF
Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology PALM SPRINGS, CA NPI 1508024852
Browse related groups: Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology CA Telix Pharmaceuticals All categories
General Payments — all program years on this page
$414,113.34
- Category: General Payments
- Program years: PY2018–2024
- Record count: 588
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $53,832.99 across 99 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $16,250.00 | 7 |
| Compensation for serving as faculty or as a speaker for a medical education program | $12,100.00 | 4 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,875.00 | 1 |
| Travel and Lodging | $9,554.73 | 26 |
| Food and Beverage | $3,310.79 | 59 |
| Honoraria | $2,742.47 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Telix Pharmaceuticals | $21,408.89 | 15 |
| Novocure Inc. | $18,303.78 | 26 |
| Medtronic, Inc. | $13,261.18 | 34 |
| Regeneron Healthcare Solutions, Inc. | $286.44 | 3 |
| Janssen Biotech, Inc. | $61.53 | 2 |
| Acerta Pharma LLC | $56.91 | 2 |
| ERBE USA INC | $50.00 | 1 |
| icotec Medical Inc. | $49.54 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $36.62 | 2 |
| INTUITIVE SURGICAL, INC. | $34.56 | 1 |
| Karyopharm Therapeutics Inc. | $32.24 | 1 |
| Astellas Pharma US Inc | $30.73 | 1 |
| SpringWorks Therapeutics, Inc. | $26.40 | 1 |
| PFIZER INC. | $26.03 | 1 |
| EISAI INC. | $25.04 | 1 |
| Siemens Medical Solutions USA, Inc. | $24.32 | 1 |
| ARRAY BIOPHARMA INC | $23.55 | 1 |
| Rigel Pharmaceuticals, Inc. | $22.84 | 1 |
| ABBVIE INC. | $22.67 | 1 |
| Blueprint Medicines Corporation | $19.08 | 1 |
| GENZYME CORPORATION | $16.00 | 1 |
| EMD Serono, Inc. | $14.64 | 1 |
By program year
Records — PY2024 (99)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.